Vascular Biogenics ^{Priced, Nasdaq: VBLT}

Developing gene therapies for cancer and small molecules for inflammation.

Industry: Health Care

First Day Return: -2.5%

Industry: Health Care

VBLT

Developing gene therapies for cancer and small molecules for inflammation.

more less

IPO News for Vascular Biogenics

US IPO Pricing Recap: 11 IPOs trade poorly but investors can't get enough American Addiction 10/03/14
Vascular Biogenics prices previously canceled IPO at $6 10/02/14
US IPO Pricing Recap: 15 IPOs in the most active week since 2007; 66% ended at or below IPO price 08/01/14

IPO Data
IPO File Date	06/06/2014
Offer Price	$6.00
Price Range $13.00 - $15.00
Offer Shares (mm)	6.7
Deal Size ($mm)	$40
Lock-Up Date	IPO Pro Only
Street Research	IPO Pro Only

IPO Data
IPO Date	09/30/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$40
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Or Yehuda, Israel
Founded	2000
Employees at IPO	32
Website www.vblrx.com

IPO News for Vascular Biogenics

Vascular Biogenics (VBLT) Performance